It was recently hypothesized that IDH mutations in NSCLC are branching drivers (Rodriguez et al. 2020) and enhance cell proliferation through Fibulin-5 methylation (Yan et al. 2018). This evidence concerns the gene FBLN5 and non-small cell lung carcinoma.